Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2018-03-30 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
2017年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2017 by 福安药业（集团）股份有限公司. It discusses the company's internal control evaluation, including financial and non-financial control deficiencies, risk assessments, control activities, and future plans. The content is focused on internal control effectiveness and compliance with regulatory internal control standards. It is not a full annual report (10-K), audit report (AR), or earnings release (ER). It is a detailed report on internal control self-assessment, which fits the category of Audit Report / Information (AR) as it relates to internal control evaluation and audit-related information but is not the full annual financial report. The document length (8127 characters) and detailed content support it being a substantive report rather than a brief announcement or certification. Therefore, the best classification is AR (Audit Report / Information). FY 2017
2018-03-30 Chinese
独立董事2017年度述职报告（李群英）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2017 by an independent director of the company. It details the director's attendance at board and shareholder meetings, opinions on company matters, committee work, investigations, and efforts to protect investor rights during the year. The content is a narrative report on the director's duties and activities rather than a full financial report or audit. It is not an Annual Report (10-K), Audit Report (AR), or Management Report (MDA). It is also not a regulatory filing or announcement but a specific report by an independent director on their duties and opinions. This fits best under Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length is under 5,000 characters, but it is a substantive report, not just an announcement of a report. Therefore, the classification is MANG with high confidence.
2018-03-30 Chinese
关于变更公司办公地址的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about the change of the company's office address. It contains no financial data, no mention of financial results, no regulatory filings, no voting results, no management changes, or other report types. It is a general regulatory announcement informing investors about the new office location. The document length is only 620 characters, indicating it is a brief notice rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2018-03-30 Chinese
关于召开2017年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2017 Annual General Meeting (AGM) of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It includes information about the meeting date, voting procedures, agenda items to be discussed and voted on (including the 2017 annual report, audit report, financial statements, profit distribution plan, and reappointment of auditors), registration details, and proxy voting instructions. The document does not contain the actual annual report, financial statements, or audit report, but rather serves as a formal notification to shareholders about the AGM and the matters to be considered. It is a typical AGM notice document, not the report itself or the voting results. Therefore, the appropriate classification is AGM Information (AGM-R).
2018-03-30 Chinese
关于举行2017年度网上业绩说明会的通知
Investor Presentation Classification · 95% confidence The document is a notice about holding the 2017 annual online earnings presentation (业绩说明会) scheduled for April 9, 2018. It references the 2017 annual report having been published on March 31, 2018, but does not contain the report itself or detailed financial data. The document is an announcement inviting investors to attend the earnings presentation, which is consistent with an Investor Presentation (IP) type filing. The document length is short and it serves as a notification for the event rather than the full report or transcript. Therefore, the correct classification is Investor Presentation (IP).
2018-03-30 Chinese
东莞证券股份有限公司关于公司发行股份及支付现金购买资产并募集配套资金暨关联交易2017年度业绩承诺实现情况之核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion on the 2017 annual performance commitment fulfillment related to a major asset acquisition and related party transaction by 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It includes audited profit commitments for 2015, 2016, and 2017, compensation arrangements, and the final conclusion that the compensation obligation is not triggered. The document references specific audit reports and agreements, and provides substantive financial data and analysis regarding the performance commitment fulfillment. It is not a brief announcement or a certification letter but a comprehensive verification report on a specific financial transaction and performance commitment. This fits the category of an Audit Report / Information (AR) because it is a standalone audit-related verification report on the performance commitment, not a full annual report or interim report, nor a simple announcement or presentation. FY 2017
2018-03-30 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.